Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC2 |
Variant | V1623G |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TSC2 V1623G (corresponding to V1646G in the canonical isoform) lies within the Rap-GAP domain of the Tsc2 protein (UniProt.org). V1623G results in the loss of repression of Mtorc1 as indicated by assays demonstrating increased phosphorylation of S6k in cultured cells (PMID: 18854862). |
Associated Drug Resistance | |
Category Variants Paths |
TSC2 mutant TSC2 inact mut TSC2 V1623G |
Transcript | NM_001114382.3 |
gDNA | chr16:g.2086819T>G |
cDNA | c.4868T>G |
Protein | p.V1623G |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001406670.1 | chr16:g.2087921T>G | c.4868T>G | p.V1623G | RefSeq | GRCh38/hg38 |
NM_001114382.2 | chr16:g.2086819T>G | c.4868T>G | p.V1623G | RefSeq | GRCh38/hg38 |
NM_001406675.1 | chr16:g.2088063T>G | c.4868T>G | p.V1623G | RefSeq | GRCh38/hg38 |
NM_001114382.3 | chr16:g.2086819T>G | c.4868T>G | p.V1623G | RefSeq | GRCh38/hg38 |
NM_001406665.1 | chr16:g.2086828T>G | c.4868T>G | p.V1623G | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|